LONDON MARKET PRE-OPEN: AstraZeneca Gets Positive News In US And China Read More
TOP NEWS: Astra, Merck & Co's Lynparza Approved For Cancer Treatment Read More
LONDON MARKET PRE-OPEN: Astra's Lynparza Approved; Rio Restarts RBM Read More
AstraZeneca's Triple-Combination Therapy Approved In China Read More
US FDA Approves AstraZeneca Breast Cancer Treatment Enhertu Read More
LONDON MARKET MIDDAY: Stocks Mixed Ahead Of Johnson's Brexit Deal Vote Read More
LONDON MARKET OPEN: Shell Dips After Warning Over Earnings Hit Read More
AstraZeneca Sells Two Cancer Drug Rights For Up To USD198 Million Read More
LONDON MARKET PRE-OPEN: AstraZeneca Sells Cancer Drug Rights Read More
AstraZeneca Says Lynparza Recommended By FDA For Pancreatic Cancer Read More
UK BROKER RATINGS SUMMARY: JPMorgan Cuts Rio And BHP, Raises Anglo Read More
AstraZeneca Divests Seroquel, Seroquel XR Rights In Europe And Russia Read More
UK BROKER RATINGS SUMMARY: Bank Of America Upgrades HSBC To Buy Read More
AstraZeneca Receives Marketing Authorization In China For Imfinzi Read More
Astra's Trastuzumab Deruxtecan Achieves Tumour Response Rate Of 60.9% Read More
UK WINNERS & LOSERS SUMMARY: Tullow Plunges On Output Guidance Reset Read More
DeepMatter Shares Surge On AstraZeneca DigitalGlassware Collaboration Read More
Positive Results From AstraZeneca Trial Of Calquence Drug In Leukaemia Read More
AstraZeneca, Merck Get Marketing Authorization In China For Lynparza Read More
AstraZeneca Divests North American Seroquel and Seroquel XR Rights Read More
